Sympathetic Nervous System Mediation of Acute Exercise Effects on Childhood Brain and Cognition

November 7, 2023 updated by: Chuck Hillman, Northeastern University

Today's children have become increasingly inactive and unfit, with >50% of children not meeting the recommended 60 min of moderate-to-vigorous physical activity. Previous research has suggested that acute aerobic exercise of moderate intensity was associated with improved cognition manifested by improved performance and increased P3 amplitude, a neuroelectric indicator that reflects the amount of attentional allocation, in tasks requiring cognitive control. While minimal evidence exists to support potential mechanisms underlying the transient effects of exercise on brain and cognition, research suggests that phasic changes in the locus coeruleus-norepinephrine (LC-NE) (as measured by salivary alpha amylase (sAA)) system are a potential mechanism for explaining the acute effect of exercise on brain and cognition. Accordingly, the aim of this study is to examine the mechanisms linking acute aerobic exercise to improved cognitive control as well as the underlying neuroelectrical activities in children, using electroencephalography (EEG) and event-related potentials (ERPs). We hope to gain a better understanding of the role of acute exercise and cognitive and brain health. The results from this study will help identify mechanisms linking acute exercise to enhanced cognitive performance in children.

Our hypothesis is that exercise-induced phasic increases in sympathetic nervous system activity will mediate the effect of a single bout of exercise on brain function, cognition, and standardized achievement test performance.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 8 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Parental/guardian consent (non-consent of guardian).
  • Participants must have had no prior diagnosis of cognitive or physical disability, including attention deficit hyperactivity disorder (severe asthma, epilepsy, chronic kidney disease, and dependence upon a wheelchair/walking aid).
  • Participants must be free of any type of anti-psychotic, anti-depressant, anti-anxiety medication, as well as those medications used for attention deficit hyperactivity disorder (use of any anti-psychotic, anti-depressant, anti-anxiety, and attention deficit hyperactivity disorder medications).
  • Normal or corrected-to-normal vision based on the minimal 20/20 standard in order to complete the cognitive task (below 20/20 vision).
  • Participants must have not yet reached, or be in the earliest stages, of puberty, as measured by a modified test of the Tanner Staging System (onset of puberty as determined by Tanner).
  • English speaking.

Exclusion Criteria:

  • Participants with an intelligence quotient below 85 will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic Exercise Intervention
Participants will exercise on a motor-driven treadmill at a constant speed during the 23-min period.
The protocol will include a 25-min bout of exercise at an intensity of 75% HRmax, such that participants will engage in a 1-min warm up and a 1-min cool down, with the majority of time (i.e., 23-min) spent exercising at 75% of HRmax.
Active Comparator: Trier Social Stress Test for Children
The Trier Social Stress Test for Children consists of a speech task in which children must finish a story and a mental arithmetic task, completed in front of a camera and two neutral observers.
Participants will be asked to imagine that they are in a new class with 20 other students, and that their teacher has asked them to stand in front of the class and introduce themselves. The mental arithmetic task will entail asking children to serially subtract the number 5 from a larger number as quickly as possible.
Placebo Comparator: Seated Rest
Participants will sit in a comfortable chair, placed in the same room as the motor-driven treadmill, for a period of 25-min.
Children will be asked to sit quietly or read a book of their choosing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neuroelectric outcome
Time Frame: baseline
P3 - ERP
baseline
Neuroelectric outcome
Time Frame: ~1 hr after arriving at lab, after completing the experimental condition
P3 - ERP
~1 hr after arriving at lab, after completing the experimental condition
inhibitory control
Time Frame: baseline
accuracy
baseline
inhibitory control
Time Frame: baseline
reaction time
baseline
working memory
Time Frame: baseline
accuracy
baseline
working memory
Time Frame: baseline
reaction time
baseline
inhibitory control
Time Frame: ~1 hr after arriving at lab, after completing the experimental condition
accuracy
~1 hr after arriving at lab, after completing the experimental condition
inhibitory control
Time Frame: ~1 hr after arriving at lab, after completing the experimental condition
reaction time
~1 hr after arriving at lab, after completing the experimental condition
working memory
Time Frame: ~1 hr after arriving at lab, after completing the experimental condition
accuracy
~1 hr after arriving at lab, after completing the experimental condition
working memory
Time Frame: ~1 hr after arriving at lab, after completing the experimental condition
reaction time
~1 hr after arriving at lab, after completing the experimental condition
Academic Achievement outcome
Time Frame: ~1.5 hrs after arriving at lab, after completing the experimental condition
WRAT3 (Wide Range, Inc., Wilmington, DE) Reading Accuracy
~1.5 hrs after arriving at lab, after completing the experimental condition
Academic Achievement outcome
Time Frame: ~1.5 hrs after arriving at lab, after completing the experimental condition
WRAT3 (Wide Range, Inc., Wilmington, DE) Spelling Accuracy
~1.5 hrs after arriving at lab, after completing the experimental condition
Academic Achievement outcome
Time Frame: ~1.5 hrs after arriving at lab, after completing the experimental condition
WRAT3 (Wide Range, Inc., Wilmington, DE) Math Accuracy
~1.5 hrs after arriving at lab, after completing the experimental condition

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2019

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

October 1, 2024

Study Registration Dates

First Submitted

June 12, 2018

First Submitted That Met QC Criteria

July 9, 2018

First Posted (Actual)

July 19, 2018

Study Record Updates

Last Update Posted (Estimated)

November 8, 2023

Last Update Submitted That Met QC Criteria

November 7, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 1R01HD094054-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Aerobic Exercise Intervention

3
Subscribe